TFFP - TFF Pharmaceuticals, Inc.

NasdaqGM - NasdaqGM Real-time price. Currency in USD
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2022
31/12/2021
31/12/2020
31/12/2019
Total revenue
0
0
0
0
0
Operating expenses
Research development
21,281
18,496
21,301
10,682
8,822
Selling general and administrative
13,427
13,796
10,574
8,012
3,165
Total operating expenses
34,512
31,797
31,787
18,694
11,988
Operating income or loss
-34,512
-31,797
-31,787
-18,694
-11,988
Total other income/expenses net
-
-
696.714
-
-
Income before tax
-34,447
-31,770
-31,039
-18,567
-11,870
Income from continuing operations
-34,447
-31,770
-31,039
-18,567
-11,870
Net income
-34,447
-31,770
-31,039
-18,567
-11,870
Net income available to common shareholders
-34,447
-31,770
-31,039
-18,567
-36,675
Basic EPS
-
-
-1.25
-0.91
-5.31
Diluted EPS
-
-
-1.25
-0.91
-5.31
Basic average shares
-
-
24,821
20,425
6,905
Diluted average shares
-
-
24,821
20,425
6,905
EBITDA
-
-31,409
-31,675
-18,694
-11,988